Michael Geschwind is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 36 publications with 1,646 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Sponsor: University of Wisconsin, Madison
- Clinical Trial Readiness for SCA1 and SCA3
Sponsor: The Methodist Hospital Research Institute
- CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20252 payments
- Lilly USA, LLCProgram year20245 payments$22,282openpaymentsdata.cms.gov ↗
- Sage TherapeuticsProgram year20241 paymentResearch$21,594openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Vesicular Monoamine Transporter 2 Inhibitor100%Tetrabenazine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2003–2023 per NIH RePORTER. The latest:
- Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2023$1,086,202R01AG062562 - Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2022$1,146,463R01AG062562 - Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2021$1,186,626R01AG062562
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Steven Deeks, MD
University of California, San Francisco
Michael Shlipak, MD
University of California, San Francisco
Bruce Miller, MD
University of California, San Francisco (UCSF)
David Knopman, MD
Mayo Clinic Rochester
Brett Kissela, MD
Medical College of Wisconsin
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”